lumistar optima luminescence counter (BMG Labtech)
BMG Labtech is a verified supplier 
BMG Labtech manufactures this product 
96
Structured Review
BMG Labtech
lumistar optima luminescence counter
Lumistar Optima Luminescence Counter, supplied by BMG Labtech, used in various techniques. Bioz Stars score: 96/100, based on 662 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lumistar+optima+luminescence+counter/LUMIstar+Omega/bio_rxiv__64898__2026__03__18__712374-221-21-25
Average 96 stars, based on 662 article reviews
Lumistar Optima Luminescence Counter, supplied by BMG Labtech, used in various techniques. Bioz Stars score: 96/100, based on 662 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lumistar+optima+luminescence+counter/LUMIstar+Omega/bio_rxiv__64898__2026__03__18__712374-221-21-25
Average 96 stars, based on 662 article reviews
lumistar optima luminescence counter - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Luciferase:Article Title: Lack of dominant-negative activity for tumor-associated ZNRF3 missense mutations at endogenous expression levels Article Snippet: .. Firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay system (Promega) according to the manufacturer’s instruction in a Article Title: Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling Article Snippet: We measured luciferase activities and normalized the data for the transfection efficiency using the Dual Luciferase Reporter Assay system (cat. #E1910, Promega). .. Luciferase activities were measured in a Article Title: RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer. Article Snippet: L-Wnt3A or L-control conditioned medium (diluted 30-fold in normal growth medium) was added after 16 h. Cells were lysed in passive lysis buffer (Promega) 48 h after transfection. .. Next, the firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega) using a Article Title: Lack of dominant-negative activity for tumor-related ZNRF3 missense mutations at endogenous levels Article Snippet: .. Firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay system (Promega) according to the manufacturer’s instruction in a Article Title: RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer Article Snippet: L-Wnt3A or L-control conditioned medium (diluted 30-fold in normal growth medium) was added after 16 h. Cells were lysed in passive lysis buffer (Promega) 48 h after transfection. .. Next, the firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega) using a Article Title: Reassessment of RNF43 Function Reveals No Impact on Endogenous EGFR or BRAF Protein Stability Article Snippet: .. Firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay system (Promega) according to the manufacturer’s instructions in a Article Title: Lack of dominant-negative activity for tumor-related ZNRF3 missense mutations at endogenous levels. Article Snippet: .. Firefly and Renilla luciferase activity was measured with the DualLuciferase Reporter Assay system (Promega) according to the manufacturer’s instruction in a Article Title: Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling Article Snippet: We measured luciferase activities and normalized the data for the transfection efficiency using the Dual Luciferase Reporter Assay system (cat. #E1910, Promega). .. Luciferase activities were measured in a Activity Assay:Article Title: Lack of dominant-negative activity for tumor-associated ZNRF3 missense mutations at endogenous expression levels Article Snippet: .. Firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay system (Promega) according to the manufacturer’s instruction in a Article Title: RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer. Article Snippet: L-Wnt3A or L-control conditioned medium (diluted 30-fold in normal growth medium) was added after 16 h. Cells were lysed in passive lysis buffer (Promega) 48 h after transfection. .. Next, the firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega) using a Article Title: Lack of dominant-negative activity for tumor-related ZNRF3 missense mutations at endogenous levels Article Snippet: .. Firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay system (Promega) according to the manufacturer’s instruction in a Article Title: RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer Article Snippet: L-Wnt3A or L-control conditioned medium (diluted 30-fold in normal growth medium) was added after 16 h. Cells were lysed in passive lysis buffer (Promega) 48 h after transfection. .. Next, the firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega) using a Article Title: Reassessment of RNF43 Function Reveals No Impact on Endogenous EGFR or BRAF Protein Stability Article Snippet: .. Firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay system (Promega) according to the manufacturer’s instructions in a Article Title: Lack of dominant-negative activity for tumor-related ZNRF3 missense mutations at endogenous levels. Article Snippet: .. Firefly and Renilla luciferase activity was measured with the DualLuciferase Reporter Assay system (Promega) according to the manufacturer’s instruction in a Reporter Assay:Article Title: Lack of dominant-negative activity for tumor-associated ZNRF3 missense mutations at endogenous expression levels Article Snippet: .. Firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay system (Promega) according to the manufacturer’s instruction in a Article Title: RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer. Article Snippet: L-Wnt3A or L-control conditioned medium (diluted 30-fold in normal growth medium) was added after 16 h. Cells were lysed in passive lysis buffer (Promega) 48 h after transfection. .. Next, the firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega) using a Article Title: Lack of dominant-negative activity for tumor-related ZNRF3 missense mutations at endogenous levels Article Snippet: .. Firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay system (Promega) according to the manufacturer’s instruction in a Article Title: RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer Article Snippet: L-Wnt3A or L-control conditioned medium (diluted 30-fold in normal growth medium) was added after 16 h. Cells were lysed in passive lysis buffer (Promega) 48 h after transfection. .. Next, the firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega) using a Article Title: Reassessment of RNF43 Function Reveals No Impact on Endogenous EGFR or BRAF Protein Stability Article Snippet: .. Firefly and Renilla luciferase activity was measured with the Dual-Luciferase Reporter Assay system (Promega) according to the manufacturer’s instructions in a Article Title: Lack of dominant-negative activity for tumor-related ZNRF3 missense mutations at endogenous levels. Article Snippet: .. Firefly and Renilla luciferase activity was measured with the DualLuciferase Reporter Assay system (Promega) according to the manufacturer’s instruction in a |